Aspire Biopharma Holdings (ASBP) Notes Payables (2021 - 2025)
Aspire Biopharma Holdings (ASBP) posted quarterly Notes Payables of $40954.0 for Q4 2025, down 95.55% year-over-year from $920240.0 in Q4 2024, and down 98.85% quarter-over-quarter from $3.6 million in Q3 2025.
Aspire Biopharma Holdings (ASBP) Notes Payables (2021 - 2025) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Notes Payables for 3 consecutive years, with $40954.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Notes Payables fell 95.55% year-over-year to $40954.0; the TTM figure through Dec 2025 stood at $40954.0 (down 95.55% YoY), while the FY2025 annual figure was $40954.0, down 95.55% from the prior year.
- Notes Payables eased to $40954.0 in Q4 2025 per ASBP's latest filing, from $3.6 million in the prior quarter.
- Across five years, Notes Payables topped out at $3.6 million in Q3 2025 and bottomed at $40954.0 in Q4 2025.
- Historically, Notes Payables has averaged $1.2 million across 3 years, with a median of $1.1 million in 2024.
- On a YoY basis, Notes Payables climbed as much as 95.55% in 2025 and fell as far as 95.55% in 2025.
- Aspire Biopharma Holdings' Notes Payables stood at $238596.0 in 2021, then surged by 285.69% to $920240.0 in 2024, then plunged by 95.55% to $40954.0 in 2025.
- Business Quant data shows ASBP's Notes Payables at $40954.0 in Q4 2025, $3.6 million in Q3 2025, and $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Aspire Biopharma Holdings | 8.30 Mn | -3.86 Mn | -30,086.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40,954.00 |
| Sep 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 920,240.00 |
| Dec 31, 2021 | 238,596.00 |